BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 25618409)

  • 1. Cardiomyocyte-specific expression of CYP2J2 prevents development of cardiac remodelling induced by angiotensin II.
    He Z; Zhang X; Chen C; Wen Z; Hoopes SL; Zeldin DC; Wang DW
    Cardiovasc Res; 2015 Mar; 105(3):304-17. PubMed ID: 25618409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP2J2 overexpression attenuates nonalcoholic fatty liver disease induced by high-fat diet in mice.
    Chen G; Xu R; Zhang S; Wang Y; Wang P; Edin ML; Zeldin DC; Wang DW
    Am J Physiol Endocrinol Metab; 2015 Jan; 308(2):E97-E110. PubMed ID: 25389366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sialyltransferase7A promotes angiotensin II-induced cardiomyocyte hypertrophy via HIF-1α-TAK1 signalling pathway.
    Yan X; Zhao R; Feng X; Mu J; Li Y; Chen Y; Li C; Yao Q; Cai L; Jin L; Han C; Zhang D
    Cardiovasc Res; 2020 Jan; 116(1):114-126. PubMed ID: 30854566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Choline ameliorates cardiac hypertrophy by regulating metabolic remodelling and UPRmt through SIRT3-AMPK pathway.
    Xu M; Xue RQ; Lu Y; Yong SY; Wu Q; Cui YL; Zuo XT; Yu XJ; Zhao M; Zang WJ
    Cardiovasc Res; 2019 Mar; 115(3):530-545. PubMed ID: 30165480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP epoxygenase 2J2 prevents cardiac fibrosis by suppression of transmission of pro-inflammation from cardiomyocytes to macrophages.
    Yang L; Ni L; Duan Q; Wang X; Chen C; Chen S; Chaugai S; Zeldin DC; Tang JR; Wang DW
    Prostaglandins Other Lipid Mediat; 2015; 116-117():64-75. PubMed ID: 25686540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baicalein attenuates angiotensin II-induced cardiac remodeling via inhibition of AKT/mTOR, ERK1/2, NF-κB, and calcineurin signaling pathways in mice.
    Wang AW; Song L; Miao J; Wang HX; Tian C; Jiang X; Han QY; Yu L; Liu Y; Du J; Xia YL; Li HH
    Am J Hypertens; 2015 Apr; 28(4):518-26. PubMed ID: 25362112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Puerarin inhibits angiotensin II-induced cardiac hypertrophy via the redox-sensitive ERK1/2, p38 and NF-κB pathways.
    Chen G; Pan SQ; Shen C; Pan SF; Zhang XM; He QY
    Acta Pharmacol Sin; 2014 Apr; 35(4):463-75. PubMed ID: 24608673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP2J2 metabolites, epoxyeicosatrienoic acids, attenuate Ang II-induced cardiac fibrotic response by targeting Gα
    He Z; Yang Y; Wen Z; Chen C; Xu X; Zhu Y; Wang Y; Wang DW
    J Lipid Res; 2017 Jul; 58(7):1338-1353. PubMed ID: 28554983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP2J2-Derived EETs Attenuated Angiotensin II-Induced Adventitial Remodeling via Reduced Inflammatory Response.
    Zhou C; Huang J; Chen J; Lai J; Zhu F; Xu X; Wang DW
    Cell Physiol Biochem; 2016; 39(2):721-39. PubMed ID: 27459385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epoxyeicosatrienoic acid prevents maladaptive remodeling in pressure overload by targeting calcineurin/NFAT and Smad-7.
    Li X; Chu G; Zhu F; Zheng Z; Wang X; Zhang G; Wang F
    Exp Cell Res; 2020 Jan; 386(1):111716. PubMed ID: 31734152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYP2J2 and its metabolites (epoxyeicosatrienoic acids) attenuate cardiac hypertrophy by activating AMPKα2 and enhancing nuclear translocation of Akt1.
    Wang B; Zeng H; Wen Z; Chen C; Wang DW
    Aging Cell; 2016 Oct; 15(5):940-52. PubMed ID: 27416746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of soluble epoxide hydrolase inhibition and CYP2J2 overexpression on postischemic cardiac function in aged mice.
    Chaudhary KR; Zordoky BN; Edin ML; Alsaleh N; El-Kadi AO; Zeldin DC; Seubert JM
    Prostaglandins Other Lipid Mediat; 2013; 104-105():8-17. PubMed ID: 22922020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardioprotective mechanism of telmisartan via PPAR-gamma-eNOS pathway in dahl salt-sensitive hypertensive rats.
    Kobayashi N; Ohno T; Yoshida K; Fukushima H; Mamada Y; Nomura M; Hirata H; Machida Y; Shinoda M; Suzuki N; Matsuoka H
    Am J Hypertens; 2008 May; 21(5):576-81. PubMed ID: 18437150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BMP-7 attenuates left ventricular remodelling under pressure overload and facilitates reverse remodelling and functional recovery.
    Merino D; Villar AV; García R; Tramullas M; Ruiz L; Ribas C; Cabezudo S; Nistal JF; Hurlé MA
    Cardiovasc Res; 2016 Jun; 110(3):331-45. PubMed ID: 27068510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin Attenuates Angiotensin II-induced Cardiomyocyte Hypertrophy by Inhibiting the Ca(2+)/Calcineurin-NFAT Signaling Pathway.
    Yin Z; Wang X; Zhang L; Zhou H; Wei L; Dong X
    Cardiovasc Ther; 2016 Feb; 34(1):21-9. PubMed ID: 26506219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYP2J2 and EETs protect against lung ischemia/reperfusion injury via anti-inflammatory effects in vivo and in vitro.
    Chen W; Yang S; Ping W; Fu X; Xu Q; Wang J
    Cell Physiol Biochem; 2015; 35(5):2043-54. PubMed ID: 25870948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stachydrine hydrochloride suppresses phenylephrine-induced pathological cardiac hypertrophy by inhibiting the calcineurin/nuclear factor of activated T-cell signalling pathway.
    Zheng J; Tian J; Wang S; Hu P; Wu Q; Shan X; Zhao P; Zhang C; Guo W; Xu M; Chen H; Lu R
    Eur J Pharmacol; 2020 Sep; 883():173386. PubMed ID: 32712088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NLRX1 knockout aggravates lipopolysaccharide (LPS)-induced heart injury and attenuates the anti-LPS cardioprotective effect of CYP2J2/11,12-EET by enhancing activation of NF-κB and NLRP3 inflammasome.
    Zhao G; Wang X; Edwards S; Dai M; Li J; Wu L; Xu R; Han J; Yuan H
    Eur J Pharmacol; 2020 Aug; 881():173276. PubMed ID: 32574674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of peroxisome proliferator-activated receptor γ (PPARγ) through NF-κB/Brg1 and TGF-β1 pathways attenuates cardiac remodeling in pressure-overloaded rat hearts.
    Qi HP; Wang Y; Zhang QH; Guo J; Li L; Cao YG; Li SZ; Li XL; Shi MM; Xu W; Li BY; Sun HL
    Cell Physiol Biochem; 2015; 35(3):899-912. PubMed ID: 25633415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP2J2-derived epoxyeicosatrienoic acids suppress endoplasmic reticulum stress in heart failure.
    Wang X; Ni L; Yang L; Duan Q; Chen C; Edin ML; Zeldin DC; Wang DW
    Mol Pharmacol; 2014 Jan; 85(1):105-15. PubMed ID: 24145329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.